Access of medication review for people living with dementia: An analysis of inequality using Swedish register data
Only 16%-21% of people with dementia received a medication review in 2015-2016 in Sweden. Higher comorbidity, polypharmacy, and residential care increased likelihood of receiving a medication review. Being married or cohabiting lowered the chance of receiving a medication review. Education level and gender did not affect access to medication reviews.
Authors
- Håkan Toresson
- Sofie Persson (ORCID: https://orcid.org/0000-0001-8372-0908)
- Ulf‐G. Gerdtham (ORCID: https://orcid.org/0000-0002-0647-7817)
- Sanjib Saha (ORCID: https://orcid.org/0000-0001-8649-0773)
- Patrik Midlöv (ORCID: https://orcid.org/0000-0002-5871-8731)
- Johan Jarl (ORCID: https://orcid.org/0000-0002-9274-2479)
- Cecilia Lenander (ORCID: https://orcid.org/0000-0003-0553-7432)
- Dominic Trépel (ORCID: https://orcid.org/0000-0002-1421-2966)
- Elisabet Londos (ORCID: https://orcid.org/0000-0002-8192-3354)
- B.A. Lawlor
Institutions
- Statistics Sweden (SE)
- Malmö University (SE)
- Lund University (SE)
- Trinity College Dublin (IE)
- Swedish Institute for Health Economics (SE)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/alz.70909
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Vetenskapsrådet
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd